Abstract:Abstract Background and aims The modulation of serum lipids, in particular of the low-density lipoprotein cholesterol (LDL-C), by statins varies between individuals. The mechanisms regulating this interindividual variation are only poorly understood. Here, we investigated the relation between the gut microbiome and the regulatory properties of atorvastatin on the serum lipidome using mice with depleted gut microbiome. Methods Over a period of 6 weeks, mice (C57BL/6) with either an intact (conventional mice, CONV, n=24) or antibiotic-based depleted gut microbiome (antibiotic treated mice, ABS, n=16) were put on standard chow diet (SCD) or high fat diet (HFD), respectively. During the last 4 weeks of treatment atorvastatin (Ator, 10mg/kg body weight/day) or control vehicle was administered via daily oral gavage. Blood lipids (total cholesterol, VLDL, LDL-C, HDL-C) and serum sphingolipids were compared among the groups. The expressions of hepatic and intestinal genes involved in cholesterol metabolism were analyzed by qRT-PCR. Alterations in the gut microbiota profile of mice with intact gut microbiome were examined using 16S RNA qRT-PCR. Results In CONV mice, HFD led to significantly increased blood LDL-C levels as compared with SCD (HFD: 36.8±1.4 mg/dl vs. SCD: 22.0±1.8 mg/dl; P<0.01). In CONV mice atorvastatin treatment significantly reduced blood LDL-C levels after HFD, whereas in ABS mice the LDL-C lowering effect of atorvastatin was markedly attenuated (CONV+HFD+Ator: 31.0±1.8 mg/dl vs. ABS+HFD+Ator: 46.4±3 mg/dl; P<0.01). A significant reduction in the abundance of several plasma lipids, in particular sphingolipids and glycerophospholipids upon atorvastatin treatment was observed in CONV mice, but not in ABS mice. The expressions of distinct hepatic and intestinal cholesterol-regulating genes (ldlr, srebp2, pcsk9 and npc1l1) upon atorvastatin treatment were significantly altered in gut microbiota depleted mice. In response to HFD a decrease in the relative abundance of the bacterial phyla Bacteroides and an increase in the relative abundance of Firmicutes was observed. The altered ratio between Bacteroides and Firmicutes in HFD fed mice was partly reversed upon atorvastatin treatment. Conclusions Our findings indicate a crucial role of the gut microbiome for the regulatory properties of atorvastatin on the serum lipidome and, in turn, support a critical impact of atorvastatin on the gut microbial composition. The results provide novel insights into potential microbiota related mechanisms underlying interindividual variation in modulation of the serum lipidome by statins, given interindividual differences in microbiome composition and function. Funding Acknowledgement Type of funding source: Foundation. Main funding source(s): German Heart Research Foundation

Characterization of interactions of dietary cholesterol with the murine and human gut microbiome

Sulfonation metabolism in gut microbiota is the main metabolic pathway of cholesterol in hypercholesterolemic mice

Interactions between dietary cholesterol and intestinal flora and their effects on host health

Metabolism of Cholesterol and Bile Acids by the Gut Microbiota

Antibiotic-induced gut microbiota depletion exacerbates host hypercholesterolemia

Effect of Gut Microbiota on Blood Cholesterol: A Review on Mechanisms

Gut microbiota Turicibacter strains differentially modify bile acids and host lipids

Intestinal Bacteria Interplay With Bile and Cholesterol Metabolism: Implications on Host Physiology

Continuum of Host-Gut Microbial Co-metabolism: Host CYP3A4/3A7 are Responsible for Tertiary Oxidations of Deoxycholate Species.

Alteration of Gut Microbiota in Association with Cholesterol Gallstone Formation in Mice

A Top-Down Systems Biology View of Microbiome-Mammalian Metabolic Interactions in A Mouse Model

Gut Commensal Christensenella Minuta Modulates Host Metabolism Via Acylated Secondary Bile Acids

Microbiota Prevents Cholesterol Loss from the Body by Regulating Host Gene Expression in Mice

A selective gut bacterial bile salt hydrolase alters host metabolism

Microbial impact on cholesterol and bile acid metabolism: current status and future prospects

Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia

Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids

Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues

Impact of the gut microbiome on the atorvastatin-dependent modulation of the serum lipidome

Global chemical effects of the microbiome include new bile-acid conjugations

Interaction of genotype and diet on small intestine microbiota of Japanese quail fed a cholesterol enriched diet